What does Anri invest in?

Anri (Tokyo, Japan) — stage focus: Seed.

How do I contact Anri?

Anri's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.

Anri — Venture Capital in Tokyo

About Anri

ANRI is a Tokyo-based independent venture capital firm founded in 2012 by Anri Samata, recognized as one of Japan’s largest seed-stage investors. The firm’s investment thesis targets seed and early-stage Japanese startups, with a focus on sectors including healthcare, consumer, fintech, internet, and deep tech. ANRI typically writes checks between $100,000 and $5 million, with a sweet spot around $1.5 million, and often acts as a lead investor in early rounds. Notable portfolio companies include N.B.Medical, which received a $5.0M Series B investment from ANRI in March 2026, as well as over 200 other startups supported since inception. The firm manages over ¥70 billion in cumulative assets under management, including its ¥30 billion fifth flagship fund and a targeted ¥50 billion sixth fund. ANRI distinguishes itself through a strong emphasis on supporting female founders and maintaining close collaboration with entrepreneurs, guided by the motto “CHANGE before YOU HAVE TO”.

Anri at a glance

Location: Tokyo, Japan
Investor type: Venture Capital
Stages: Seed

Frequently asked about Anri

What does Anri invest in?: Anri (Tokyo, Japan) — stage focus: Seed.
How do I contact Anri?: Anri's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is Anri headquartered?: Anri is based in Tokyo, Japan.

Details on this firm come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Tokyo.

Anri

About Anri

Anri at a glance

Frequently asked about Anri

Investors similar to Anri (20)

Browse related investor lists (2)

Compare Anri (8)